Recently, it was reported that in various tumors, such as liver cancer, gastric cancer, lung cancer, and breast cancer, the expression level of RBM proteins is related to the tumor size, invasion depth, lymph node metastasis, and prognosis. Here, RBMY1A1 is linked to neoplasm.